STAT3 and neoplasm: STAT3 has proven to be an ideal drug target, as sustained activation of STAT3 and strong dependence on STAT3 activity has been identified in approximately 70% of blood and solid tumors, and is involved in tumor proliferation, survival, self-renewal, invasion, and angiogenesis (Calò et al., 2003; Frank, 2007).